MRI-based diagnosis and treatment of pediatric brain tumors: is tissue sample always needed?
Image-based diagnosis
Magnetic resonance imaging
Pediatric brain tumors
Pediatric neuroradiology
Pediatric neurosurgery
Surgical biopsy
Journal
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
02
12
2020
accepted:
24
03
2021
pubmed:
7
4
2021
medline:
29
6
2021
entrez:
6
4
2021
Statut:
ppublish
Résumé
Traditional management of newly diagnosed pediatric brain tumors (PBTs) consists of cranial imaging, typically magnetic resonance imaging (MRI), and is frequently followed by tissue diagnosis, through either surgical biopsy or tumor resection. Therapy regimes are typically dependent on histological diagnosis. To date, many treatment regimens are based on molecular biology. The scope of this article is to discuss the role of diagnosis and further treatment of PBTs based solely on MRI features, in light of the latest treatment protocols. Typical MRI findings and indications for surgical biopsy of these lesions are described.
Identifiants
pubmed: 33821340
doi: 10.1007/s00381-021-05148-1
pii: 10.1007/s00381-021-05148-1
pmc: PMC8084800
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1449-1459Références
Pierre-Aurélien B, Alexandru S, Federico DR et al (2016) Diffuse intrinsic pontine glioma in children: document or treat? World Neurosurg 93:485.e11–485.e14. https://doi.org/10.1016/j.wneu.2016.07.011
doi: 10.1016/j.wneu.2016.07.011
Cohen KJ, Jabado N, Grill J (2017) Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro Oncol 19:1025–1034. https://doi.org/10.1093/neuonc/nox021
doi: 10.1093/neuonc/nox021
pubmed: 28371920
pmcid: 5570259
Puget S, Beccaria K, Blauwblomme T, Roujeau T, James S, Grill J, Zerah M, Varlet P, Sainte-Rose C (2015) Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas. Childs Nerv Syst 31:1773–1780. https://doi.org/10.1007/s00381-015-2832-1
doi: 10.1007/s00381-015-2832-1
pubmed: 26351229
Makepeace L, Scoggins M, Mitrea B, Li Y, Edwards A, Tinkle CL, Hwang S, Gajjar A, Patay Z (2020) MRI patterns of extrapontine lesion extension in diffuse intrinsic pontine gliomas. Am J Neuroradiol 41:323–330. https://doi.org/10.3174/ajnr.A6391
doi: 10.3174/ajnr.A6391
pubmed: 31974084
Tisnado J, Young R, Peck KK, Haque S (2016) Conventional and advanced imaging of diffuse intrinsic pontine glioma. J Child Neurol 31:1386–1393. https://doi.org/10.1177/0883073816634855
doi: 10.1177/0883073816634855
pubmed: 27071471
pmcid: 5659185
Epstein F, Wisoff JH (1988) Intrinsic brainstem tumors in childhood: surgical indications. J Neuro-Oncol 6:309–317
doi: 10.1007/BF00177425
Epstein F (1985) A staging system for brain stem gliomas. Cancer 56:1804–1806. https://doi.org/10.1002/1097-0142(19851001)56:7+<1804::aid-cncr2820561316>3.0.co;2-5
doi: 10.1002/1097-0142(19851001)56:7+<1804::aid-cncr2820561316>3.0.co;2-5
pubmed: 4027915
Epstein FJ (1987) Prognosis in pediatric brain-stem gliomas. J Neurosurg 67:323–324
doi: 10.3171/jns.1987.67.4.0483
Kieran MW (2017) Lessons learned from diffuse intrinsic pontine glioma: how a terrible disease forced us to think better. Neuro-Oncol 19:1017–1018. https://doi.org/10.1093/neuonc/nox022
doi: 10.1093/neuonc/nox022
pubmed: 28541486
pmcid: 5570137
Pollack IF, Agnihotri S, Broniscer A (2019) Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr 23:261–273. https://doi.org/10.3171/2018.10.PEDS18377
doi: 10.3171/2018.10.PEDS18377
pubmed: 30835699
pmcid: 6823600
Walker DA, Liu J, Kieran M, Jabado N, Picton S, Packer R, St. Rose C, (on behalf of the CPN Paris 2011 Conference Consensus Group), van Meeteren AS, Carvalho A, van Damme A, Depreitere B, Gustavsson B, Due Tonnessen BJ, Bertozzi-Salamon AI, Brentrup A, Raybaud C, Jones C, Dufour C, Dorfer C, Sainte-Rose C, Malluci C, Hargrave D, Walker D, van Vuurden D, de Carli E, Bouffet E, van Calenbergh F, Frappaz D, Frassanito P, Goodrich J, Baechli H, Grill J, Ternier J, Cappelen J, Caird J, Pereira J, Riffaud L, Baroncini M, Walker M, Kieran M, Ozek M, Jabado N, Nysom K, Varlet P, Goodden J, Bertolini P, Perilongo G, Mercier P, Grundy R, Kortmann RD, Packer R, Pfister S, Constantini S, Sgouros S, Holm S, Czech T, Merchant T, Stokland T, Ridola V, Vandertop P (2013) A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method. Neuro-Oncol 15:462–468. https://doi.org/10.1093/neuonc/nos330
doi: 10.1093/neuonc/nos330
pubmed: 23502427
pmcid: 3607269
Lobon-Iglesias M-J, Santa-Maria Lopez V, Puerta Roldan P, Candela-Cantó S, Ramos-Albiac M, Gomez-Chiari M, Puget S, Bolle S, Goumnerova L, Kieran MW, Cruz O, Grill J, Morales la Madrid A (2018) Tumor dissemination through surgical tracts in diffuse intrinsic pontine glioma. J Neurosurg Pediatr 22:678–683. https://doi.org/10.3171/2018.6.PEDS17658
doi: 10.3171/2018.6.PEDS17658
pubmed: 30192215
Pfaff E, El Damaty A, Balasubramanian GP et al (2019) Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience. Eur J Cancer 114:27–35. https://doi.org/10.1016/j.ejca.2019.03.019
doi: 10.1016/j.ejca.2019.03.019
pubmed: 31022591
Hamisch C, Kickingereder P, Fischer M, Simon T, Ruge MI (2017) Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. J Neurosurg Pediatr 20:261–268. https://doi.org/10.3171/2017.2.PEDS1665
doi: 10.3171/2017.2.PEDS1665
pubmed: 28621573
Cocco E, Scaltriti M, Drilon A (2018) NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 15:731–747. https://doi.org/10.1038/s41571-018-0113-0
doi: 10.1038/s41571-018-0113-0
pubmed: 30333516
pmcid: 6419506
Ternier J, Wray A, Puget S, Bodaert N, Zerah M, Sainte-Rose C (2006) Tectal plate lesions in children. J Neurosurg 104:369–376. https://doi.org/10.3171/ped.2006.104.6.369
doi: 10.3171/ped.2006.104.6.369
pubmed: 16776370
Igboechi C, Vaddiparti A, Sorenson EP, Rozzelle CJ, Tubbs RS, Loukas M (2013) Tectal plate gliomas: a review. Childs Nerv Syst 29:1827–1833. https://doi.org/10.1007/s00381-013-2110-z
doi: 10.1007/s00381-013-2110-z
pubmed: 23612874
Stark AM, Fritsch MJ, Claviez A, Dörner L, Mehdorn HM (2005) Management of tectal glioma in childhood. Pediatr Neurol 33:33–38. https://doi.org/10.1016/j.pediatrneurol.2004.12.014
doi: 10.1016/j.pediatrneurol.2004.12.014
pubmed: 15876519
Griessenauer CJ, Rizk E, Miller JH, Hendrix P, Tubbs RS, Dias MS, Riemenschneider K, Chern JJ (2014) Pediatric tectal plate gliomas: clinical and radiological progression, MR imaging characteristics, and management of hydrocephalus. J Neurosurg Pediatr 13:13–20. https://doi.org/10.3171/2013.9.PEDS13347
doi: 10.3171/2013.9.PEDS13347
pubmed: 24180680
Kaufmann A, Gerber NU, Kandels D, Azizi A, Schmidt R, Warmuth-Metz M, Pietsch T, Kortmann RD, Gnekow A, Grotzer M (2018) Management of primary tectal plate low-grade glioma in pediatric patients: results of the multicenter treatment study SIOP-LGG 2004. Neuropediatrics 49:314–323. https://doi.org/10.1055/s-0038-1660503
doi: 10.1055/s-0038-1660503
pubmed: 29890518
Liu APY, Harreld JH, Jacola LM, Gero M, Acharya S, Ghazwani Y, Wu S, Li X, Klimo P Jr, Gajjar A, Chiang J, Qaddoumi I (2018) Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis. Acta Neuropathol Commun 6:101. https://doi.org/10.1186/s40478-018-0602-5
doi: 10.1186/s40478-018-0602-5
pubmed: 30253793
pmcid: 6154813
Roth J, Chaichana KL, Jallo G, Mirone G, Cinalli G, Constantini S (2015) True aqueductal tumors: a unique entity. Acta Neurochir 157:169–177. https://doi.org/10.1007/s00701-014-2264-9
doi: 10.1007/s00701-014-2264-9
pubmed: 25377385
Roth J, Constantini S (2015) Combined rigid and flexible endoscopy for tumors in the posterior third ventricle. J Neurosurg 122:1341–1346. https://doi.org/10.3171/2014.9.JNS141397
doi: 10.3171/2014.9.JNS141397
pubmed: 25816082
Steinbok P, Gopalakrishnan CV, Hengel AR, Vitali AM, Poskitt K, Hawkins C, Drake J, Lamberti-Pasculli M, Ajani O, Hader W, Mehta V, McNeely PD, McDonald PJ, Ranger A, Vassilyadi M, Atkinson J, Ryall S, Eisenstat DD, Hukin J (2016) Pediatric thalamic tumors in the MRI era: a Canadian perspective. Childs Nerv Syst 32:269–280. https://doi.org/10.1007/s00381-015-2968-z
doi: 10.1007/s00381-015-2968-z
pubmed: 26597682
Di Rocco C, Iannelli A (2002) Bilateral thalamic tumors in children. Childs Nerv Syst 18:440–444. https://doi.org/10.1007/s00381-002-0609-9
doi: 10.1007/s00381-002-0609-9
pubmed: 12192503
Puget S, Crimmins DW, Garnett MR, Grill J, Oliveira R, Boddaert N, Wray A, Lelouch-Tubiana A, Roujeau T, di Rocco F, Zerah M, Sainte-Rose C (2007) Thalamic tumors in children: a reappraisal. J Neurosurg 106:354–362. https://doi.org/10.3171/ped.2007.106.5.354
doi: 10.3171/ped.2007.106.5.354
pubmed: 17566201
Gudowius S, Engelbrecht V, Messing-Jünger M, Reifenberger G, Gärtner J (2002) Diagnostic difficulties in childhood bilateral thalamic astrocytomas. Neuropediatrics 33:331–335. https://doi.org/10.1055/s-2002-37085
doi: 10.1055/s-2002-37085
pubmed: 12571791
Menon G, Nair S, Sudhir J, Rao BRM, Krishnakumar K (2010) Bilateral thalamic lesions. Br J Neurosurg 24:566–571. https://doi.org/10.3109/02688691003777915
doi: 10.3109/02688691003777915
pubmed: 20536292
Broniscer A, Hwang SN, Chamdine O, Lin T, Pounds S, Onar-Thomas A, Chi L, Shurtleff S, Allen S, Gajjar A, Northcott P, Orr BA (2018) Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts. Brain Pathol 28:112–120. https://doi.org/10.1111/bpa.12484
doi: 10.1111/bpa.12484
pubmed: 28032389
Sievers P, Sill M, Schrimpf D, Stichel D, Reuss DE, Sturm D, Hench J, Frank S, Krskova L, Vicha A, Zapotocky M, Bison B, Castel D, Grill J, Debily MA, Harter PN, Snuderl M, Kramm CM, Reifenberger G, Korshunov A, Jabado N, Wesseling P, Wick W, Solomon DA, Perry A, Jacques TS, Jones C, Witt O, Pfister SM, von Deimling A, Jones DTW, Sahm F (2020) A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR. Neuro Oncol. 23:34–43. https://doi.org/10.1093/neuonc/noaa251
doi: 10.1093/neuonc/noaa251
Mondal G, Lee JC, Ravindranathan A, Villanueva-Meyer JE, Tran QT, Allen SJ, Barreto J, Gupta R, Doo P, van Ziffle J, Onodera C, Devine P, Grenert JP, Samuel D, Li R, Metrock LK, Jin LW, Antony R, Alashari M, Cheshier S, Whipple NS, Bruggers C, Raffel C, Gupta N, Kline CN, Reddy A, Banerjee A, Hall MD, Mehta MP, Khatib Z, Maher OM, Brathwaite C, Pekmezci M, Phillips JJ, Bollen AW, Tihan T, Lucas JT Jr, Broniscer A, Berger MS, Perry A, Orr BA, Solomon DA (2020) Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol (Berl) 139:1071–1088. https://doi.org/10.1007/s00401-020-02155-5
doi: 10.1007/s00401-020-02155-5
Trevisson E, Cassina M, Opocher E, Vicenzi V, Lucchetta M, Parrozzani R, Miglionico G, Mardari R, Viscardi E, Midena E, Clementi M (2017) Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1. J Neuro-Oncol 134:279–287. https://doi.org/10.1007/s11060-017-2517-6
doi: 10.1007/s11060-017-2517-6
Campen CJ, Gutmann DH (2018) Optic pathway gliomas in neurofibromatosis type 1. J Child Neurol 33:73–81. https://doi.org/10.1177/0883073817739509
doi: 10.1177/0883073817739509
pubmed: 29246098
pmcid: 5739070
Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189–198. https://doi.org/10.1002/ana.21107
doi: 10.1002/ana.21107
pubmed: 17387725
Farazdaghi MK, Katowitz WR, Avery RA (2019) Current treatment of optic nerve gliomas. Curr Opin Ophthalmol 30:356–363. https://doi.org/10.1097/ICU.0000000000000587
doi: 10.1097/ICU.0000000000000587
pubmed: 31246635
pmcid: 7410088
Prada CE, Hufnagel RB, Hummel TR et al (2015) The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. J Pediatr 167:851–856.e1. https://doi.org/10.1016/j.jpeds.2015.07.001
doi: 10.1016/j.jpeds.2015.07.001
pubmed: 26233602
Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81–88. https://doi.org/10.1136/jmg.2006.045906
doi: 10.1136/jmg.2006.045906
pubmed: 17105749
Beres SJ (2018) Optic pathway gliomas in neurofibromatosis type 1: imaging and monitoring. Int Ophthalmol Clin 58:97–112. https://doi.org/10.1097/IIO.0000000000000241
doi: 10.1097/IIO.0000000000000241
pubmed: 30239366
Rosser T, Packer RJ (2002) Intracranial neoplasms in children with neurofibromatosis 1. J Child Neurol 17:630–637; discussion 646-651. https://doi.org/10.1177/088307380201700815
doi: 10.1177/088307380201700815
pubmed: 12403562
Packer RJ, Iavarone A, Jones DTW, Blakeley JO, Bouffet E, Fisher MJ, Hwang E, Hawkins C, Kilburn L, MacDonald T, Pfister SM, Rood B, Rodriguez FJ, Tabori U, Ramaswamy V, Zhu Y, Fangusaro J, Johnston SA, Gutmann DH (2020) Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference. Neuro-Oncol 22:773–784. https://doi.org/10.1093/neuonc/noaa036
doi: 10.1093/neuonc/noaa036
pubmed: 32055852
pmcid: 7283027
Thomas RP, Gibbs IC, Xu LW, Recht L (2015) Treatment options for optic pathway gliomas. Curr Treat Options Neurol 17:333. https://doi.org/10.1007/s11940-014-0333-2
doi: 10.1007/s11940-014-0333-2
pubmed: 25619537
Shofty B, Ben-Sira L, Freedman S, Yalon M, Dvir R, Weintraub M, Toledano H, Constantini S, Kesler A (2011) Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatr Blood Cancer 57:481–485. https://doi.org/10.1002/pbc.22967
doi: 10.1002/pbc.22967
pubmed: 21241008
Shofty B, Mauda-Havakuk M, Weizman L, Constantini S, Ben-Bashat D, Dvir R, Pratt LT, Joskowicz L, Kesler A, Yalon M, Ravid L, Ben-Sira L (2015) The effect of chemotherapy on optic pathway gliomas and their sub-components: a volumetric MR analysis study. Pediatr Blood Cancer 62:1353–1359. https://doi.org/10.1002/pbc.25480
doi: 10.1002/pbc.25480
pubmed: 25858021
National Cancer Institute (NCI) (2020) Current treatment of optic nerve gliomas. https://clinicaltrials.gov/ct2/show/NCT03871257 . Accessed 2 April 2021
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M (2019) Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 20:1011–1022. https://doi.org/10.1016/S1470-2045(19)30277-3
doi: 10.1016/S1470-2045(19)30277-3
pubmed: 31151904
pmcid: 6628202
Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL, Franz DN, Wang HZ (2013) Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 49:439–444. https://doi.org/10.1016/j.pediatrneurol.2013.08.017
doi: 10.1016/j.pediatrneurol.2013.08.017
pubmed: 24138953
Katz JS, Milla SS, Wiggins GC, Devinsky O, Weiner HL, Roth J (2012) Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus. J Neurosurg Pediatr 9:406–413. https://doi.org/10.3171/2011.12.PEDS11418
doi: 10.3171/2011.12.PEDS11418
pubmed: 22462706
Katz JS, Frankel H, Ma T, Zagzag D, Liechty B, Zeev BB, Tzadok M, Devinsky O, Weiner HL, Roth J (2017) Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation. Childs Nerv Syst 33:601–607. https://doi.org/10.1007/s00381-017-3335-z
doi: 10.1007/s00381-017-3335-z
pubmed: 28074282
Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group (2013) Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:243–254. https://doi.org/10.1016/j.pediatrneurol.2013.08.001
doi: 10.1016/j.pediatrneurol.2013.08.001
pubmed: 24053982
pmcid: 4080684
Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Berkowitz N, Anak O, Niolat J, Jozwiak S (2014) Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol 15:1513–1520. https://doi.org/10.1016/S1470-2045(14)70489-9
doi: 10.1016/S1470-2045(14)70489-9
pubmed: 25456370
Harter DH, Bassani L, Rodgers SD, Roth J, Devinsky O, Carlson C, Wisoff JH, Weiner HL (2014) A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. J Neurosurg Pediatr 13:21–28. https://doi.org/10.3171/2013.9.PEDS13193
doi: 10.3171/2013.9.PEDS13193
pubmed: 24180681
Yalon M, Ben-Sira L, Constantini S, Toren A (2011) Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex. Childs Nerv Syst 27:179–181. https://doi.org/10.1007/s00381-010-1222-y
doi: 10.1007/s00381-010-1222-y
pubmed: 20703486
French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Berkowitz N, Voi M, Peyrard S, Pelov D, Franz DN (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 388:2153–2163. https://doi.org/10.1016/S0140-6736(16)31419-2
doi: 10.1016/S0140-6736(16)31419-2
pubmed: 27613521
Bissler JJ, Budde K, Sauter M, Franz DN, Zonnenberg BA, Frost MD, Belousova E, Berkowitz N, Ridolfi A, Christopher Kingswood J (2019) Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2. Nephrol Dial Transplant 34:1000–1008. https://doi.org/10.1093/ndt/gfy132
doi: 10.1093/ndt/gfy132
pubmed: 30053159
Weidman DR, Palasamudram S, Zak M, Whitney R, McCoy B, Bouffet E, Taylor M, Shroff M, Bartels U (2020) The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). J Neuro-Oncol 147:731–736. https://doi.org/10.1007/s11060-020-03487-8
doi: 10.1007/s11060-020-03487-8
Cuccia V, Alderete D (2010) Suprasellar/pineal bifocal germ cell tumors. Childs Nerv Syst 26:1043–1049. https://doi.org/10.1007/s00381-010-1120-3
doi: 10.1007/s00381-010-1120-3
pubmed: 20221609
Phi JH, Kim S-K, Lee J, Park CK, Kim IH, Ahn HS, Shin HY, Kim IO, Jung HW, Kim DG, Paek SH, Wang KC (2013) The enigma of bifocal germ cell tumors in the suprasellar and pineal regions: synchronous lesions or metastasis? J Neurosurg Pediatr 11:107–114. https://doi.org/10.3171/2012.10.PEDS11487
doi: 10.3171/2012.10.PEDS11487
pubmed: 23198842
Wu C-C, Guo W-Y, Chang F-C, Luo CB, Lee HJ, Chen YW, Lee YY, Wong TT (2017) MRI features of pediatric intracranial germ cell tumor subtypes. J Neuro-Oncol 134:221–230. https://doi.org/10.1007/s11060-017-2513-x
doi: 10.1007/s11060-017-2513-x
Lafay-Cousin L, Millar B-A, Mabbott D, Spiegler B, Drake J, Bartels U, Huang A, Bouffet E (2006) Limited-field radiation for bifocal germinoma. Int J Radiat Oncol Biol Phys 65:486–492. https://doi.org/10.1016/j.ijrobp.2005.12.011
doi: 10.1016/j.ijrobp.2005.12.011
pubmed: 16530340
Morana G, Alves CA, Tortora D, Finlay JL, Severino M, Nozza P, Ravegnani M, Pavanello M, Milanaccio C, Maghnie M, Rossi A, Garrè ML (2018) T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study. Neuroradiology 60:89–99. https://doi.org/10.1007/s00234-017-1947-3
doi: 10.1007/s00234-017-1947-3
pubmed: 29128947
Ogino H, Shibamoto Y, Takanaka T, Suzuki K, Ishihara SI, Yamada T, Sugie C, Nomoto Y, Mimura M (2005) CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome. Int J Radiat Oncol Biol Phys 62:803–808. https://doi.org/10.1016/j.ijrobp.2004.10.026
doi: 10.1016/j.ijrobp.2004.10.026
pubmed: 15936563
Kim CH, Paek SH, Park IA, Chi JG, Kim DG (2002) Cerebral germinoma with hemiatrophy of the brain: report of three cases. Acta Neurochir 144:145–150. https://doi.org/10.1007/s007010200017
doi: 10.1007/s007010200017
pubmed: 11862514
Yamanaka R, Hayano A, Takashima Y (2019) Trilateral retinoblastoma: a systematic review of 211 cases. Neurosurg Rev 42:39–48. https://doi.org/10.1007/s10143-017-0890-4
doi: 10.1007/s10143-017-0890-4
pubmed: 28815312
de Jong MC, Kors WA, de Graaf P et al (2015) The incidence of trilateral retinoblastoma: a systematic review and meta-analysis. Am J Ophthalmol 160:1116–1126.e5. https://doi.org/10.1016/j.ajo.2015.09.009
doi: 10.1016/j.ajo.2015.09.009
pubmed: 26374932
de Graaf P, Göricke S, Rodjan F et al (2012) Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol 42:2–14. https://doi.org/10.1007/s00247-011-2201-5
doi: 10.1007/s00247-011-2201-5
pubmed: 21850471
Rodjan F, de Graaf P, Brisse HJ, Göricke S, Maeder P, Galluzzi P, Aerts I, Alapetite C, Desjardins L, Wieland R, Popovic MB, Diezi M, Munier FL, Hadjistilianou T, Knol DL, Moll AC, Castelijns JA (2012) Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission. J Neuro-Oncol 109:535–544. https://doi.org/10.1007/s11060-012-0922-4
doi: 10.1007/s11060-012-0922-4
Bagley LJ, Hurst RW, Zimmerman RA, Shields JA, Shields CL, de Potter P (1996) Imaging in the trilateral retinoblastoma syndrome. Neuroradiology 38:166–170. https://doi.org/10.1007/BF00604810
doi: 10.1007/BF00604810
pubmed: 8692433
Shofty B, Artzi M, Ben Bashat D, Liberman G, Haim O, Kashanian A, Bokstein F, Blumenthal DT, Ram Z, Shahar T (2018) MRI radiomics analysis of molecular alterations in low-grade gliomas. Int J Comput Assist Radiol Surg 13:563–571. https://doi.org/10.1007/s11548-017-1691-5
doi: 10.1007/s11548-017-1691-5
pubmed: 29270916
Fetit AE, Novak J, Rodriguez D, Auer DP, Clark CA, Grundy RG, Peet AC, Arvanitis TN (2018) Radiomics in paediatric neuro-oncology: a multicentre study on MRI texture analysis. NMR Biomed 31. https://doi.org/10.1002/nbm.3781
Hara JH, Wu A, Villanueva-Meyer JE, Valdes G, Daggubati V, Mueller S, Solberg TD, Braunstein SE, Morin O, Raleigh DR (2018) Clinical applications of quantitative 3-dimensional MRI analysis for pediatric embryonal brain tumors. Int J Radiat Oncol Biol Phys 102:744–756. https://doi.org/10.1016/j.ijrobp.2018.05.077
doi: 10.1016/j.ijrobp.2018.05.077
pubmed: 30108003
Iv M, Zhou M, Shpanskaya K, Perreault S, Wang Z, Tranvinh E, Lanzman B, Vajapeyam S, Vitanza NA, Fisher PG, Cho YJ, Laughlin S, Ramaswamy V, Taylor MD, Cheshier SH, Grant GA, Young Poussaint T, Gevaert O, Yeom KW (2019) MR imaging-based radiomic signatures of distinct molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 40:154–161. https://doi.org/10.3174/ajnr.A5899
doi: 10.3174/ajnr.A5899
pubmed: 30523141
pmcid: 6330121
Li M, Wang H, Shang Z, Yang Z, Zhang Y, Wan H (2020) Ependymoma and pilocytic astrocytoma: differentiation using radiomics approach based on machine learning. J Clin Neurosci 78:175–180. https://doi.org/10.1016/j.jocn.2020.04.080
doi: 10.1016/j.jocn.2020.04.080
pubmed: 32336636
Guerrini-Rousseau L, Abbas R, Huybrechts S, Kieffer-Renaux V, Puget S, Andreiuolo F, Beccaria K, Blauwblomme T, Bolle S, Dhermain F, Longaud Valès A, Roujeau T, Sainte-Rose C, Tauziede-Espariat A, Varlet P, Zerah M, Valteau-Couanet D, Dufour C, Grill J (2020) Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children. Neuro-Oncol. 22:1686–1695. https://doi.org/10.1093/neuonc/noaa083
doi: 10.1093/neuonc/noaa083
pubmed: 32267940
pmcid: 7846143
Bounajem MT, Karsy M, Jensen RL (2020) Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons. Neurosurg Focus 48:E8. https://doi.org/10.3171/2019.9.FOCUS19712
doi: 10.3171/2019.9.FOCUS19712
pubmed: 31896088
Hao X, Guo Z, Sun H, Liu X, Zhang Y, Zhang L, Sun W, Tian Y (2020) Urinary protein biomarkers for pediatric medulloblastoma. J Proteome 225:103832. https://doi.org/10.1016/j.jprot.2020.103832
doi: 10.1016/j.jprot.2020.103832
Sareen H, Garrett C, Lynch D, Powter B, Brungs D, Cooper A, Po J, Koh ES, Vessey JY, McKechnie S, Bazina R, Sheridan M, Gelder J, Darwish B, Jaeger M, Roberts TL, de Souza P, Becker TM (2020) The role of liquid biopsies in detecting molecular tumor biomarkers in brain cancer patients. Cancers 12:1831. https://doi.org/10.3390/cancers12071831
doi: 10.3390/cancers12071831
pmcid: 7408771
Soleman J, Roth J, Ram Z, Yalon M, Constantini S (2017) Malignant transformation of a conservatively managed incidental childhood cerebral mass lesion: controversy regarding management paradigm. Childs Nerv Syst 33:2169–2175. https://doi.org/10.1007/s00381-017-3566-z
doi: 10.1007/s00381-017-3566-z
pubmed: 28808787
Kamenova M, Leu S, Mariani L, Schaeren S, Soleman J (2016) Management of incidental dural tear during lumbar spine surgery. To suture or not to suture? World Neurosurg 87:455–462. https://doi.org/10.1016/j.wneu.2015.11.045
doi: 10.1016/j.wneu.2015.11.045
pubmed: 26700751
Hochart A, Gaillard V, Baroncini M, André N, Vannier JP, Vinchon M, Dubrulle F, Lejeune JP, Vincent C, Nève V, Sudour Bonnange H, Bonne NX, Leblond P (2015) Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2. J Neuro-Oncol 124:229–236. https://doi.org/10.1007/s11060-015-1828-8
doi: 10.1007/s11060-015-1828-8
Renzi S, Michaeli O, Salvador H, Alderete D, Ponce NF, Zapotocky M, Hansford JR, Malalasekera VS, Toledano H, Maguire B, Bouffet E, Ramaswamy V, Baroni LV (2020) Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence. Pediatr Blood Cancer 67:e28228. https://doi.org/10.1002/pbc.28228
doi: 10.1002/pbc.28228
pubmed: 32124552